2023-2029 Global Anti-VEGF Drug Industry Research & Trends Analysis Report

Tables and Figures

Table 1. Anti-VEGF Drug Market Size & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Anti-VEGF Drug Market Restraints
Table 3. Anti-VEGF Drug Market Trends
Table 4. Anti-VEGF Drug Industry Policy
Table 5. Global Anti-VEGF Drug Revenue by Company, 2018-2023, US$ million
Table 6. Global Anti-VEGF Drug Revenue Market Share by Company, 2018-2023
Table 7. Global Anti-VEGF Drug Sales Volume by Company, 2018-2023, (K Units)
Table 8. Global Anti-VEGF Drug Sales Volume Market Share by Company, 2018-2023
Table 9. Global Anti-VEGF Drug Price by Company, 2018-2023, (US$/Unit)
Table 10. Global Anti-VEGF Drug Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Anti-VEGF Drug Mergers & Acquisitions, Expansion Plans
Table 12. Global Anti-VEGF Drug Manufacturers Product Type
Table 13. China Anti-VEGF Drug Revenue by Company, 2018-2023, US$ million
Table 14. China Anti-VEGF Drug Revenue Market Share by Company, 2018-2023
Table 15. China Anti-VEGF Drug Sales Volume by Company, 2018-2023, (K Units)
Table 16. China Anti-VEGF Drug Sales Volume Market Share by Company, 2018-2023
Table 17. China Market, Anti-VEGF Drug Production, Sales, Import and Export, 2018-2029, (K Units)
Table 18. China Anti-VEGF Drug Import & Export Trends
Table 19. Main Sources of China Anti-VEGF Drug Import
Table 20. Export Destination of China Anti-VEGF Drug
Table 21. Global Headquarters and Manufacturing Base of Anti-VEGF Drug Manufacturers
Table 22. Global Major Manufacturers, Anti-VEGF Drug Capacity Expansion and Future Plans
Table 23. Global Anti-VEGF Drug Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 24. Global Anti-VEGF Drug Production by Region, 2018-2023, (K Units)
Table 25. Global Anti-VEGF Drug Production Forecast by Region, 2023-2029, (K Units)
Table 26. Global Key Players of Anti-VEGF Drug Upstream (Raw Materials)
Table 27. Global Anti-VEGF Drug Typical Customers
Table 28. Anti-VEGF Drug Typical Distributors
Table 29. By Type, Global Anti-VEGF Drug Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Application, Global Anti-VEGF Drug Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 31. By Region, Global Anti-VEGF Drug Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 32. By Region, Global Anti-VEGF Drug Revenue, 2018-2029, US$ Million
Table 33. By Region, Global Anti-VEGF Drug Sales Volume, 2018-2029, (K Units)
Table 34. By Country, Global Anti-VEGF Drug Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million
Table 35. By Country, Global Anti-VEGF Drug Revenue, 2018-2029, US$ Million
Table 36. By Country, Global Anti-VEGF Drug Revenue Market Share, 2018-2029
Table 37. By Country, Global Anti-VEGF Drug Sales Volume, 2018-2029, (K Units)
Table 38. By Country, Global Anti-VEGF Drug Sales Volume Market Share, 2018-2029
Table 39. F. Hoffmann-La Roche Ltd Company Information, Head Office, Market Area and Industry Position
Table 40. F. Hoffmann-La Roche Ltd Anti-VEGF Drug Models, Specifications and Application
Table 41. F. Hoffmann-La Roche Ltd Anti-VEGF Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. F. Hoffmann-La Roche Ltd Company Profile and Main Business
Table 43. F. Hoffmann-La Roche Ltd Recent Developments
Table 44. Amgen Inc Company Information, Head Office, Market Area and Industry Position
Table 45. Amgen Inc Anti-VEGF Drug Models, Specifications and Application
Table 46. Amgen Inc Anti-VEGF Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Amgen Inc Company Profile and Main Business
Table 48. Amgen Inc Recent Developments
Table 49. Pfizer, Inc Company Information, Head Office, Market Area and Industry Position
Table 50. Pfizer, Inc Anti-VEGF Drug Models, Specifications and Application
Table 51. Pfizer, Inc Anti-VEGF Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Pfizer, Inc Company Profile and Main Business
Table 53. Pfizer, Inc Recent Developments
Table 54. Xbrane Biopharma AB Company Information, Head Office, Market Area and Industry Position
Table 55. Xbrane Biopharma AB Anti-VEGF Drug Models, Specifications and Application
Table 56. Xbrane Biopharma AB Anti-VEGF Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Xbrane Biopharma AB Company Profile and Main Business
Table 58. Xbrane Biopharma AB Recent Developments
Table 59. Allergan Company Information, Head Office, Market Area and Industry Position
Table 60. Allergan Anti-VEGF Drug Models, Specifications and Application
Table 61. Allergan Anti-VEGF Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Allergan Company Profile and Main Business
Table 63. Allergan Recent Developments
Table 64. Bayer AG Company Information, Head Office, Market Area and Industry Position
Table 65. Bayer AG Anti-VEGF Drug Models, Specifications and Application
Table 66. Bayer AG Anti-VEGF Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Bayer AG Company Profile and Main Business
Table 68. Bayer AG Recent Developments
Table 69. Regeneron Pharmaceuticals Inc. Company Information, Head Office, Market Area and Industry Position
Table 70. Regeneron Pharmaceuticals Inc. Anti-VEGF Drug Models, Specifications and Application
Table 71. Regeneron Pharmaceuticals Inc. Anti-VEGF Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Regeneron Pharmaceuticals Inc. Company Profile and Main Business
Table 73. Regeneron Pharmaceuticals Inc. Recent Developments
Table 74. Viatris Inc Company Information, Head Office, Market Area and Industry Position
Table 75. Viatris Inc Anti-VEGF Drug Models, Specifications and Application
Table 76. Viatris Inc Anti-VEGF Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Viatris Inc Company Profile and Main Business
Table 78. Viatris Inc Recent Developments
List of Figure
Figure 1. Anti-VEGF Drug Picture
Figure 2. By Revenue, Global Anti-VEGF Drug Market Size and Forecast, 2018-2029, US$ Million
Figure 3. By Sales Volume, Global Anti-VEGF Drug Market Size and Forecast, 2018-2029, (K Units)
Figure 4. Global Anti-VEGF Drug Price Trend, 2018-2029, (US$/Unit)
Figure 5. By Revenue, China Anti-VEGF Drug Market Size and Forecast, 2018-2029, US$ million
Figure 6. By Sales Volume, China Anti-VEGF Drug Market Size and Forecast, 2018-2029, (K Units)
Figure 7. China Anti-VEGF Drug Price Trend, 2018-2029 (US$/Unit)
Figure 8. By Revenue, China Anti-VEGF Drug Share of Global Market, 2018-2029
Figure 9. By Sales Volume, China Anti-VEGF Drug Share of Global Market, 2018-2029
Figure 10. Global Anti-VEGF Drug Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global Anti-VEGF Drug Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China Anti-VEGF Drug Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China Anti-VEGF Drug Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China Anti-VEGF Drug Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 15. Chinese Local Players, Proportion of Anti-VEGF Drug Domestic VS Export, 2022
Figure 16. Global Anti-VEGF Drug Capacity, Production and Capacity Utilization, 2018-2029
Figure 17. Global Anti-VEGF Drug Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global Anti-VEGF Drug Production Market Share & Forecast by Region, 2018-2029
Figure 19. Anti-VEGF Drug Industry Chain
Figure 20. Anti-VEGF Drug Procurement Model
Figure 21. Anti-VEGF Drug Sales Model
Figure 22. Anti-VEGF Drug Sales Channels, Direct Sales and Distribution
Figure 23. Avastin
Figure 24. Lucentis
Figure 25. Eylea
Figure 26. By Type, Global Anti-VEGF Drug Revenue, 2018-2029, US$ Million
Figure 27. By Type, Global Anti-VEGF Drug Revenue Market Share, 2018-2029
Figure 28. By Type, Global Anti-VEGF Drug Sales Volume, 2018-2029, (K Units)
Figure 29. By Type, Global Anti-VEGF Drug Sales Volume Market Share, 2018-2029
Figure 30. By Type, Global Anti-VEGF Drug Price, 2018-2029, (US$/Unit)
Figure 31. Age-related Macular Degeneration
Figure 32. Macular Edema Following Retinal Vein Occlusion
Figure 33. Diabetic Macular Edema
Figure 34. Diabetic Retinopathy
Figure 35. By Application, Global Anti-VEGF Drug Revenue, 2018-2029, US$ Million
Figure 36. By Application, Global Anti-VEGF Drug Revenue Market Share, 2018-2029
Figure 37. By Application, Global Anti-VEGF Drug Sales Volume, 2018-2029, (K Units)
Figure 38. By Application, Global Anti-VEGF Drug Sales Volume Market Share, 2018-2029
Figure 39. By Application, Global Anti-VEGF Drug Price, 2018-2029, (US$/Unit)
Figure 40. By Region, Global Anti-VEGF Drug Revenue Market Share, 2018-2029
Figure 41. By Region, Global Anti-VEGF Drug Sales Volume Market Share, 2018-2029
Figure 42. North America Anti-VEGF Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 43. By Country, North America Anti-VEGF Drug Revenue Market Share, 2022
Figure 44. Europe Anti-VEGF Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 45. By Country, Europe Anti-VEGF Drug Revenue Market Share, 2022
Figure 46. Asia Pacific Anti-VEGF Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 47. By Country/Region, Asia Pacific Anti-VEGF Drug Revenue Market Share, 2022
Figure 48. South America Anti-VEGF Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 49. By Country, South America Anti-VEGF Drug Revenue Market Share, 2022
Figure 50. Middle East & Africa Anti-VEGF Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 51. U.S. Anti-VEGF Drug Sales Volume, 2018-2029, (K Units)
Figure 52. By Company, U.S. Anti-VEGF Drug Market Share, 2022
Figure 53. By Type, U.S. Anti-VEGF Drug Sales Volume Market Share, 2022 VS 2029
Figure 54. By Application, U.S. Anti-VEGF Drug Sales Volume Market Share, 2022 VS 2029
Figure 55. Europe Anti-VEGF Drug Sales Volume, 2018-2029, (K Units)
Figure 56. By Company, Europe Anti-VEGF Drug Market Share, 2022
Figure 57. By Type, Europe Anti-VEGF Drug Sales Volume Market Share, 2022 VS 2029
Figure 58. By Application, Europe Anti-VEGF Drug Sales Volume Market Share, 2022 VS 2029
Figure 59. China Anti-VEGF Drug Sales Volume, 2018-2029, (K Units)
Figure 60. By Company, China Anti-VEGF Drug Market Share, 2022
Figure 61. By Type, China Anti-VEGF Drug Sales Volume Market Share, 2022 VS 2029
Figure 62. By Application, China Anti-VEGF Drug Sales Volume Market Share, 2022 VS 2029
Figure 63. Japan Anti-VEGF Drug Sales Volume, 2018-2029, (K Units)
Figure 64. By Company, Japan Anti-VEGF Drug Market Share, 2022
Figure 65. By Type, Japan Anti-VEGF Drug Sales Volume Market Share, 2022 VS 2029
Figure 66. By Application, Japan Anti-VEGF Drug Sales Volume Market Share, 2022 VS 2029
Figure 67. South Korea Anti-VEGF Drug Sales Volume, 2018-2029, (K Units)
Figure 68. By Company, South Korea Anti-VEGF Drug Market Share, 2022
Figure 69. By Type, South Korea Anti-VEGF Drug Sales Volume Market Share, 2022 VS 2029
Figure 70. By Application, South Korea Anti-VEGF Drug Sales Volume Market Share, 2022 VS 2029
Figure 71. Southeast Asia Anti-VEGF Drug Sales Volume, 2018-2029, (K Units)
Figure 72. By Company, Southeast Asia Anti-VEGF Drug Market Share, 2022
Figure 73. By Type, Southeast Asia Anti-VEGF Drug Sales Volume Market Share, 2022 VS 2029
Figure 74. By Application, Southeast Asia Anti-VEGF Drug Sales Volume Market Share, 2022 VS 2029
Figure 75. India Anti-VEGF Drug Sales Volume, 2018-2029, (K Units)
Figure 76. By Company, India Anti-VEGF Drug Market Share, 2022
Figure 77. By Type, India Anti-VEGF Drug Sales Volume Market Share, 2022 VS 2029
Figure 78. By Application, India Anti-VEGF Drug Sales Volume Market Share, 2022 VS 2029
Figure 79. Middle East & Asia Anti-VEGF Drug Sales Volume, 2018-2029, (K Units)
Figure 80. By Company, Middle East & Asia Anti-VEGF Drug Market Share, 2022
Figure 81. By Type, Middle East & Asia Anti-VEGF Drug Sales Volume Market Share, 2022 VS 2029
Figure 82. By Application, Middle East & Asia Anti-VEGF Drug Sales Volume Market Share, 2022 VS 2029
Figure 83. Research Methodology
Figure 84. Breakdown of Primary Interviews
Figure 85. Bottom-up Approaches
Figure 86. Top-down Approaches

Reason to Buy

• Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
• Highlights key business priorities in order to assist companies to realign their business strategies
• The segment that is expected to dominate the Pharma & Healthcare Market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets